103 related articles for article (PubMed ID: 9333990)
41. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
42. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
43. [Use of methadone in the treatment of narcotic addiction].
Tiljak H
Lijec Vjesn; 1998 May; 120(5):125-31. PubMed ID: 9748791
[TBL] [Abstract][Full Text] [Related]
44. [Methadone dose, treatment duration and heroin use in drug-assisted rehabilitation].
Kornør H; Waal H
Tidsskr Nor Laegeforen; 2004 Feb; 124(3):332-4. PubMed ID: 14963504
[TBL] [Abstract][Full Text] [Related]
45. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.
Pérez de Los Cobos J; Trujols J; Valderrama JC; Valero S; Puig T
Drug Alcohol Depend; 2005 Sep; 79(3):405-12. PubMed ID: 15869846
[TBL] [Abstract][Full Text] [Related]
46. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
47. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.
Langleben DD; Ruparel K; Elman I; Busch-Winokur S; Pratiwadi R; Loughead J; O'Brien CP; Childress AR
Am J Psychiatry; 2008 Mar; 165(3):390-4. PubMed ID: 18056224
[TBL] [Abstract][Full Text] [Related]
48. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
[TBL] [Abstract][Full Text] [Related]
49. [How do the substitution programs help in social integration of drug addicts?].
Déglon JJ
Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():100-1. PubMed ID: 7880004
[No Abstract] [Full Text] [Related]
50. [Are substitution practices indicated in withdrawal within the framework of health care of drug addicts and according to what modalities?].
Lauzon P
Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():87-8. PubMed ID: 7880036
[No Abstract] [Full Text] [Related]
51. [Reply concerning the article "Is methadone maintenance provided by private practitioners effective?' by R. Stohler et al. in SPM 49 (2004), 276-80].
Meili D; Dober S
Soz Praventivmed; 2005; 50(1):7-9; author reply 10-1. PubMed ID: 15771322
[No Abstract] [Full Text] [Related]
52. General practitioners and opiate-abusing patients.
McKeganey NP; Boddy FA
J R Coll Gen Pract; 1988 Feb; 38(307):73-5. PubMed ID: 3204571
[TBL] [Abstract][Full Text] [Related]
53. The general practitioner and drug dependence.
Paul AH
N Z Med J; 1972 Oct; 76(485):278-9. PubMed ID: 4509220
[No Abstract] [Full Text] [Related]
54. Brokerage model rehabilitation system for opiate dependence: a behavioral analysis.
Thompson T; Koerner J; Grabowski J
NIDA Res Monogr; 1984; 46():131-46. PubMed ID: 6427620
[No Abstract] [Full Text] [Related]
55. [Drug withdrawal under anesthesia--an alternative to substitution therapy. Model project in a Bavarian district hospital. Interview by Dr. rer. nat. Anita Schweiger].
Reiss J
Fortschr Med; 1996 Aug; 114(24):12-3. PubMed ID: 8974965
[No Abstract] [Full Text] [Related]
56. Heroin addiction: what can the GP do?
Manzie PP
Aust Fam Physician; 1978 Oct; 7(10):1233-40. PubMed ID: 736836
[TBL] [Abstract][Full Text] [Related]
57. Problem drug users: a problem for the GP?
Cohen J
Practitioner; 1994 Oct; 238(1543):715-8. PubMed ID: 7991487
[No Abstract] [Full Text] [Related]
58. [Reflections apropos of methadone: posology and use in the United States].
Newman RG
Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():89. PubMed ID: 7880037
[No Abstract] [Full Text] [Related]
59. Care of drug misusers.
Coombs DM
Br J Gen Pract; 1993 Apr; 43(369):176. PubMed ID: 8323813
[No Abstract] [Full Text] [Related]
60. Estimating incidence trends in regular heroin use in 26 regions of Switzerland using methadone treatment data.
Nordt C; Landolt K; Stohler R
Subst Abuse Treat Prev Policy; 2009 Jun; 4():14. PubMed ID: 19519920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]